Physician profile
Rupa Patel
NPI 1366555450
$2,310.88
in general payments reported to CMS, 2019-2025
30 companies · $18.90 in 2025
The $18.90 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $365 · 2021: $694 · 2022: $82.49 · 2023: $203 · 2025: $18.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $494.71 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $219.19 | 2019-2022 | |
| Coloplast Corp | $210.98 | 2019-2023 | Isiris Astent Removal Device |
| Pfizer INC. | $190.36 | 2019-2021 | |
| Janssen Biotech, INC. | $183.83 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $152.72 | 2019-2020 | |
| Procept Biorobotics Corporation | $122.32 | 2023 | Aquabeam Robotic System |
| Axonics, INC. | $106.24 | 2021-2022 | |
| Medtronic USA, INC. | $88.62 | 2019-2020 | |
| Boston Scientific Corporation | $69.47 | 2019-2021 | |
| Allergan, INC. | $62.10 | 2019-2020 | |
| Urogen Pharma, INC. | $35.60 | 2021 | |
| Olympus America INC. | $33.78 | 2021 | |
| Abbvie INC. | $32.09 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $30.00 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $29.96 | 2021 | |
| Amgen INC. | $29.14 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $28.51 | 2021 | |
| Myovant Sciences INC. | $27.72 | 2021 | |
| Medtronic, INC. | $24.28 | 2021 | |
| Rochester Medical Corporation | $24.13 | 2020 | |
| Hollister Incorporated | $19.46 | 2021 | |
| Daiichi Sankyo INC. | $14.99 | 2019 | |
| Urovant Sciences INC | $14.50 | 2021 | |
| Alnylam Pharmaceuticals INC. | $14.04 | 2021 | |
| Blue Earth Diagnostics | $13.42 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.36 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.94 | 2019 | |
| Aytu Biopharma, INC. | $12.42 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rupa Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.